Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

252 Press Releases
DateTitleCompany
29 Apr 16 Sanofi Comments on Medivation's Rejection of Proposal Sanofi,
Published by
GlobeNewswire
28 Apr 16 Sanofi : Sanofi Offers to Acquire Medivation for $52.50 Per Share in Cash Sanofi,
Published by
GlobeNewswire
20 Apr 16 New Data Suggesting Positive Effects of Sanofi Genzyme’s Lemtrada® (alemtuzumab) on Brain Volume Loss and Retinal Nerve Fibers to be Presented at AAN Sanofi Genzyme,
Published by
PharmiWeb.com
20 Apr 16 More than 35 Presentations of New Investigational Data from Sanofi Genzyme’s Multiple Sclerosis Franchise to be Featured at AAN Sanofi Genzyme,
Published by
PharmiWeb.com
19 Apr 16 10-year follow-up data on Lemtrada®cid:image004.png@01D1996F.E3AADBA0 (alemtuzumab) detailing clinical efficacy in people with relapsing-remitting multiple sclerosis (MS) to be presented at the American Academy of Neurology (AAN) 2016 Annual Meeting Sanofi Genzyme,
Published by
PharmiWeb.com
15 Apr 16 Strategic Advisory Group of Experts on Immunization Convened by the World Health Organization Recommends Use of Sanofi Pasteur's Dengue Vaccine in Endemic Countries Sanofi,
Published by
GlobeNewswire
14 Apr 16 Sanofi Opens Partnering Office in Stevenage Bioscience Catalyst Sanofi ,
Published by
PharmiWeb.com
08 Apr 16 Sanofi Genzyme Donates Corporate Archives To Harvard Business School Sanofi Genzyme ,
Published by
PharmiWeb.com
08 Apr 16 Sanofi: Availability of the Pre-quarterly Results Communication Sanofi,
Published by
GlobeNewswire
04 Apr 16 Sanofi: World's First Public Dengue Immunization Program Starts in the Philippines Sanofi,
Published by
GlobeNewswire
01 Apr 16 Sanofi and Regeneron Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients Sanofi,
Published by
GlobeNewswire
30 Mar 16 Sanofi : Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of ... Sanofi,
Published by
GlobeNewswire
29 Mar 16 Sanofi successfully prices EUR 1.8 billion bond issue Sanofi,
Published by
GlobeNewswire
29 Mar 16 Sanofi Appoints Dr. Yong-Jun Liu as Head of Research Sanofi,
Published by
GlobeNewswire
23 Mar 16 Sanofi and Regeneron Announce Positive Topline Results from Phase 3 Praluent® (alirocumab) Study in Patients Undergoing LDL Apheresis Therapy Sanofi,
Published by
GlobeNewswire
16 Mar 16 Sanofi and Regeneron Strongly Disagree with U.S. Jury Verdict in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection and Will Appeal Sanofi,
Published by
GlobeNewswire
16 Mar 16 Sanofi and DiCE Molecules Announce Research Collaboration to Discover Potential Therapeutics Based on Unique Small Molecule Discovery Platform Sanofi,
Published by
GlobeNewswire
11 Mar 16 Sanofi and Regeneron Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis Sanofi,
Published by
GlobeNewswire
02 Mar 16 Actress Madeleine Stowe and Sanofi Genzyme Launch New Phase of Take Action on MS with Dynamic Webisode Series Sanofi Genzyme,
Published by
Business Wire
03 Mar 16 Sanofi Genzyme Presents Results from Phase 1/2 Study of Investigational Second-Generation Therapy for Pompe Disease Sanofi,
Published by
GlobeNewswire
08 Mar 16 Sanofi Pasteur and MSD (Known as Merck in the United States and Canada) Announce Intent to End Joint Vaccines Operations in Europe, Sanofi Pasteur MSD, to Pursue Their Own Distinct Growth Strategies Sanofi,
Published by
GlobeNewswire
03 Mar 16 Sanofi's Board of Directors Proposes Appointment of Diane Souza and Thomas Südhof, MD as New Independent Directors Sanofi,
Published by
GlobeNewswire
29 Feb 16 Sanofi Genzyme Recognizes Rare Disease Day 2016 with Program of Events around the World Sanofi Genzyme,
Published by
Business Wire
04 Mar 16 Sanofi Genzyme Presents Results from Phase 1/2 Study of Investigational Second-Generation Therapy for Pompe Disease Sanofi Genzyme,
Published by
Business Wire
03 Mar 16 Sanofi Genzyme Recognises 2016 International Rare Disease Day with Premiere of Expression of Hope film Sanofi Genzyme ,
Published by
PharmiWeb.com
04 Mar 16 Sanofi: Filing of the 2015 U.S. Form 20-F and French "Document de Référence" containing the Annual Financial Report Sanofi,
Published by
GlobeNewswire
22 Feb 16 FDA Accepts Sanofi New Drug Application for Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Sanofi ,
Published by
PharmiWeb.com
10 Mar 16 Sanofi Appoints Dr. Ameet Nathwani to Executive Committee and Executive Vice President, Group Chief Medical Officer Sanofi,
Published by
GlobeNewswire
26 Feb 16 First Vaccinations against Dengue Mark Historic Moment in Prevention of Infectious Diseases Sanofi Pasteur,
Published by
PharmiWeb.com
10 Mar 16 Sanofi Appoints Dr. Ameet Nathwani to Executive Committee and Executive Vice President, Group Chief Medical Officer Sanofi ,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.